Literature DB >> 16448701

Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients.

Roberta Zanardini1, Anna Gazzoli, Mariacarla Ventriglia, Jorge Perez, Stefano Bignotti, Paolo Maria Rossini, Massimo Gennarelli, Luisella Bocchio-Chiavetto.   

Abstract

BACKGROUND: Depression has been associated with low brain-derived neurotrophic factor (BDNF) serum levels, while antidepressant drugs appear to mend this alteration. The purpose of this study was to assess BDNF serum levels in drug resistant depressed patients before and after repetitive Transcranial Magnetic Stimulation (rTMS) antidepressant treatment.
METHODS: BDNF levels were measured in serum of 16 resistant depressed patients using the ELISA technique.
RESULTS: BDNF baseline levels showed a negative correlation with illness severity measured by HDRS scores (R = -0.517, p = 0.04) and a significant increase of serum BDNF was found after rTMS treatment (t = -2.549, df = 15, p = 0.022).
CONCLUSIONS: Our findings support the relationship between decreased serum BDNF and depression symptomatology and suggest a normalizing effect of rTMS antidepressant treatment. Further replications in larger samples will help to clarify the relevance of this preliminary data in the rTMS mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448701     DOI: 10.1016/j.jad.2005.12.029

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  37 in total

1.  Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.

Authors:  Heath D Schmidt; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2010-08-04       Impact factor: 7.853

Review 2.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

Review 3.  Rehabilitating the addicted brain with transcranial magnetic stimulation.

Authors:  Marco Diana; Tommi Raij; Miriam Melis; Aapo Nummenmaa; Lorenzo Leggio; Antonello Bonci
Journal:  Nat Rev Neurosci       Date:  2017-09-29       Impact factor: 34.870

4.  Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex Induces Brain Morphological Changes in Regions Associated with a Treatment Resistant Major Depressive Episode: An Exploratory Analysis.

Authors:  Martin J Lan; Binod Thapa Chhetry; Conor Liston; J John Mann; Marc Dubin
Journal:  Brain Stimul       Date:  2016-03-02       Impact factor: 8.955

Review 5.  Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484).

Authors:  M L Molendijk; P Spinhoven; M Polak; B A A Bus; B W J H Penninx; B M Elzinga
Journal:  Mol Psychiatry       Date:  2013-08-20       Impact factor: 15.992

6.  Serial repetitive transcranial magnetic stimulation (rTMS) decreases BDNF serum levels in healthy male volunteers.

Authors:  Gerd Schaller; Wolfgang Sperling; Tanja Richter-Schmidinger; Christiane Mühle; Annemarie Heberlein; Christian Maihöfner; Johannes Kornhuber; Bernd Lenz
Journal:  J Neural Transm (Vienna)       Date:  2013-10-25       Impact factor: 3.575

Review 7.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 8.  The neurotrophic and neuroprotective effects of psychotropic agents.

Authors:  Joshua Hunsberger; Daniel R Austin; Ioline D Henter; Guang Chen
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

9.  Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy; Ramy Moharram; Irina Velicu; Brian M Martin
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

Review 10.  Early intervention in bipolar disorder, part II: therapeutics.

Authors:  Giacomo Salvadore; Wayne C Drevets; Ioline D Henter; Carlos A Zarate; Husseini K Manji
Journal:  Early Interv Psychiatry       Date:  2008-08       Impact factor: 2.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.